TruthArchive.ai - Related Video Feed

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and the need to understand what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker highlighted the need for further research in this area.

Speaker 0 asks: first, what impacts the loss of bifidobacterium? and second, what can we do to replenish it and keep it strong and populated? Speaker 1 responds that the microbiome is still in its infancy, and urges not to assume you can test your stools in the market because the FDA doesn’t have a test approved for testing stool. Regarding buying Bifidobacterium, he says that the problem with replenishing is you may suppress your own ability to make Bifidobacteria, and what Bifidobacteria needs is good nutrition, good vitamins, and good yogurt. He cites the case of a woman who lived to 117 years old in India, noting that remnants of bifidobacteria were found in her stools, and that she ate yogurt three times a day. When asked how much she ate, he replies that there aren’t studies on that, but yogurt is happening. Speaker 1 continues: in a world where we constantly dodge viruses, parasites, and bacteria that secrete toxins, survival involves doing one’s best. There are things that kill the microbiome, notably antibiotics. Therefore, when you take antibiotics, that’s the time to supplement with a good probiotic and good vitamins. He notes a problem: 16 out of 17 probiotics on the market do not have Bifidobacteria. He explains why he began focusing on Bifidobacteria: in the trillion-dollar probiotic industry, if you turn a bottle around and read the ingredients, the bacteria listed are Bifidobacteria. That observation during the pandemic sparked his interest in Bifidobacteria. He says the whole path is to save the Biff, referencing the idea that during stressful moments—political division, hate, anger—seeing the power of a microbe becomes important.

The speaker conducted a study on the impact of vaccines on the microbiome. They found a decrease in Bifidobacteria in patients post-vaccination, suggesting a potential link to the vaccine. Further research showed persistent damage to the microbiome even months later. Additionally, newborns of vaccinated mothers had no Bifidobacteria in their microbiome, raising concerns about the transfer of spike proteins through breast milk.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage that kills off certain microbes. They also observed a lack of Bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of Bifidobacteria. They shared their personal experience of trying to increase their Bifidobacteria through kefir but finding that many products claiming to contain it did not. This led them to further research and experimentation.

The speaker, a gastroenterologist, discusses research on the microbiome's role in COVID-19 and challenges faced publishing findings that went against the public health narrative. Early research documented the virus in stools for up to 45 days and showed hydroxychloroquine and azithromycin killed COVID-19 in stools, but also harmed the microbiome, necessitating vitamin C, D, and zinc. The FDA initially granted an exemption for clinical trials using this combination, then revoked it. Media-fueled fear around hydroxychloroquine hindered recruitment. Research revealed that severe COVID-19 patients lacked bifidobacteria, a key microbe for immunity, which is abundant in newborns but declines with age. Vitamin C and ivermectin were found to increase bifidobacteria. A hypothesis that ivermectin increased bifidobacteria was retracted after being widely read. Research on mRNA vaccines showed they killed bifidobacteria, presented at a gastroenterology conference, linking bifidobacteria loss to Crohn's disease, Lyme disease, and invasive cancer. The speaker concludes that research interference during the pandemic hindered scientific progress and that clinical trial guidelines were not followed.

remember, I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant. The first thing that came to me during COVID was I bet you it's in the stools. COVID can persist in the stools. Some people were asymptomatic and had COVID in their stools, but yet never had symptoms. What was the difference between those people? The difference was their bifidobacteria. Forty three severe patients with COVID had zero Bifidobacteria. Bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID. Anecdotal studies like of kimchi and sauerkraut because obviously you can talk to people that ate sauerkraut and still got COVID.

The speaker observed that patients with severe COVID were missing bifidobacteria compared to those highly exposed but uninfected. Bifidobacteria is a key microbe for immunity and is present in newborns but absent in older people. The speaker's research indicated vitamin C increases bifidobacteria, which may explain its use for treating colds. Ivermectin also increased bifidobacteria within 24 hours, possibly because it's a fermented product of a similar bacteria. The speaker hypothesized that ivermectin's observed benefits in COVID patients might be due to increased bifidobacteria. This hypothesis was the most read during the pandemic but was later retracted. The speaker believes the retraction of a hypothesis is not in the spirit of science.

The speaker, a gastroenterologist, discusses their research on the microbiome and COVID-19. They found that the virus lingers in stools, hydroxychloroquine kills the virus but harms the microbiome, and bifidobacteria is crucial for immunity. Their studies on vitamin C, ivermectin, and mRNA vaccines' effects on bifidobacteria faced challenges in publication due to going against the mainstream narrative. They highlight the importance of unbiased research and collaboration in finding solutions. The speaker also raises concerns about pharmaceutical companies prioritizing profits over patient safety during the pandemic.

The speaker describes microbiome work on COVID-19 and post-mRNA vaccination, noting profound microbiome effects. “I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant.” During COVID, “I bet you it's in the stools.” They found “COVID in the stools in a hundred percent of patients that were positive nasal swab” and that “COVID can persist in the stools.” Some asymptomatic individuals had COVID in stools; “the difference was their bifidobacteria.” Early anecdotal signals about kimchi and sauerkraut are discussed: “What's different between that population? Why is one person eating sauerkraut and kimchi is fine and another person not?” They observed that “forty three severe patients with COVID had zero Bifidobacteria.” They say they will “focus on Bifidobacteria, not the others, because there are some people that have zero bifidobacteria and never got COVID... create a resilience.” Finally, “So bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID.”

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also discovered that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

The speaker reflects on the pandemic, describing it as a time of “miracles,” including not losing anyone and continuing to speak today, despite controversy surrounding her research. She emphasizes that the controversy has hindered the advancement of research and science, urging instead to ask questions as science is about questioning and pushing narratives. She asserts a specific finding: the spike protein reduces bifidobacteria. She explains that the vaccine caused bifidobacteria to die within a month, but the effect persisted, with data indicating zero bifidobacteria in long-COVID or vaccine-injured cases. She notes she has been dealing with this for five years and asserts that people with zero bifidobacteria experience ongoing loss of microbiome diversity and immunity, resulting in poor immunity. She highlights bifidobacteria’s role in absorbing sugar, and adds that another microbe responsible for calcium absorption is also destroyed, leading to impaired calcium uptake. From these observations, she links cellular-level consequences to mitochondrial function, describing how a lack of sugar and calcium results in energy shortfalls and a disrupted Krebs cycle, implying mitochondrial dysfunction. She concludes that long COVID is a spike protein injury and that in many cases these individuals have zero bifidobacteria whether due to the treatment, the virus, or the spike protein itself. She also notes that some patients still have residual COVID in their stools, underscoring the need to pay attention to this finding. Key points emphasized: - The pandemic featured perceived miracles and ongoing controversy around research and vaccines, which the speaker argues stifles scientific progress. - A claim that the spike protein reduces bifidobacteria; the vaccine allegedly kills bifidobacteria within a month, with long-COVID or vaccine-injured individuals showing zero bifidobacteria across the line. - Zero bifidobacteria is linked to loss of microbial diversity, compromised immunity, and poor immune function. - Bifidobacteria’s role in absorbing sugar and a related microbe’s role in calcium absorption are highlighted as critical, with their destruction affecting cellular energy and mitochondrial function. - Long COVID is described as a spike protein injury, with some cases having residual COVID in stools, suggesting the need for attention to these microbial findings.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

Speaker introduces herself as 'the girl that brought vaccines to market' and cites data that 'the messenger RNA killed the bifidobacteria,' claiming this controversy has halted research and science. She asserts, 'What we discovered with the vaccine is that it did kill the bifida bacteria within a month, persisted in killing the bifida bacteria.' She notes daily reports of 'long COVID or vax' and outlines her interview approach: asking patients if they had COVID, were vaccinated, and whether they contracted COVID after vaccination, concluding 'did the vaccine kill their bifida bacteria.' She describes the immune concept as thinking of the body as 'a group of communities, group of gangs or communities in your gut,' warning that a 'foreigner' prompts autoimmunity. She argues vaccination may 'kill your bifidobacteria,' leading to timing effects on long COVID or vaccine injury, with 'zero bifidobacteria across the line.'

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that some products claiming to contain bifidobacteria did not actually have it. Research is ongoing to further explore these findings.

In December 2020, the speaker began collecting stool samples from colleagues before and after their COVID vaccination to study the vaccine's impact on the microbiome. The speaker discovered that mRNA vaccines killed bifidobacteria but believed these findings were unpublishable due to the prevailing narrative. The speaker presented this research as an abstract at the American College of Gastroenterology in October 2022, where it won a research award, beating 6,000 other abstracts. This abstract drew the attention of 18,000 GI doctors, who began to consider that the loss of bifidobacteria may explain why they contracted COVID after vaccination. Further research indicated persistent damage to bifidobacteria from the vaccine. The speaker's presentation also linked the loss of bifidobacteria to Crohn's disease, Lyme disease, and invasive cancer.

Speaker 0 and Speaker 1 describe findings from studying COVID and the gut microbiome, focusing on bifidobacteria. They state that their lab was the one to detect COVID in stool samples. Their central questions were what COVID does to the microbiome and how long the virus remains in the gut. They observed that one patient had COVID for up to 45 days after respiratory symptoms resolved, and another case showed the virus detectable for up to a year and a half after respiratory symptoms ended. This led them to investigate differences between people who do and do not get COVID, including households with similar exposures. A key observation was linked to bifidobacteria. They note that a difference between individuals who stayed healthy and those who contracted COVID was the level of bifidobacteria. They point out that bifidobacteria are the bacteria commonly advertised as probiotics, present in newborns and that aging is associated with its decline. They emphasize bifidobacteria as an important microbe for the microbiome and its potential role in health outcomes. The discussion includes an example: a farmer who kissed his COVID-positive wife and did not get COVID himself had high microbial diversity and a good amount of bifidobacteria, suggesting resilience due to microbial composition, including bifidobacteria. They extend the implication to mental health, noting that loss of bifidobacteria has been observed in anxiety and bipolar disorder, while acknowledging this is not the only microbe involved in those conditions. Another function attributed to bifidobacteria is aiding digestion: they help break down food to release sugars that enter cells, and assist in releasing calcium. The speakers contrast this with the broader focus on mitochondria and mitochondrial function, arguing that gut microbes initiate the process by breaking down food in the bowels to supply sugars and calcium for cellular processes. In summary, their findings indicate that people with higher bifidobacteria are more resilient to COVID and healthier, whereas those with lower bifidobacteria correlate with greater vulnerability; bifidobacteria play a role in sugar absorption, calcium release, and overall metabolic and potentially mental health outcomes. Speaker 1 and Speaker 0 confirm: people with more bifidobacteria were more resilient and did not get sick from COVID, while those who got very sick did not have enough bifidobacteria or had low levels.

Bifidobacteria is presented as a common denominator lacking in individuals with autism, Alzheimer's, cancer, anxiety, bipolar disorder, obesity, and diabetes. The speaker questioned why young people were less affected by COVID-19 compared to older, diabetic, or obese individuals, and also why some seemingly healthy individuals with autoimmune conditions were severely affected. The speaker had pre-pandemic microbiome data and observed a correlation between bifidobacteria levels and COVID-19 outcomes. High-risk individuals exposed to COVID-19 who never contracted the virus had high levels of bifidobacteria, while those who contracted the virus multiple times had zero bifidobacteria. This observation reinforced the importance of bifidobacteria, further emphasized by treatment outcomes.

The speaker highlights a widespread loss of Bifidobacteria across conditions. "Lyme disease had zero bifidobacteria." "Crohn's patients, zero bifidobacteria." "Alzheimer's patients, zero bifidobacteria." "Invasive cancer, zero bifidobacteria." When we compare to non invasive cancer, long COVID, zero bifidobacteria. "Bipolar disorder. We talk about mental health, right? Zero bifida bacteria, anxiety." The speaker notes: "Think about all the people that were so anxious during COVID. It was through the roof." It is suggested: "Is it because they killed their bifidobacteria, got the virus, and therefore, the bacteroides went up and caused that anxiety." The closing point: "So, the world of the microbiome really opened up during the pandemic."

After observing the vaccine rollout, the speaker began collecting stool samples from vaccinated doctors to analyze the vaccine's impact on the microbiome. Initial analysis of four patients revealed a decrease in Bifidobacteria post-vaccination. This trend continued across 34 patients. The speaker hypothesized that the vaccine might be creating a "Bifidofage." In four patients tracked for 90 days, Bifidobacteria levels dropped from approximately 1,000,000 to zero, and this persisted for up to nine months. The speaker also analyzed the microbiome of newborns breastfed by vaccinated mothers and found an absence of Bifidobacteria, which typically constitutes 90% of a newborn's microbiome. The speaker questions whether the spike protein is transferred through breast milk, impacting the baby's gut and killing the Bifidobacteria.

A top gastroenterologist treated a colleague who became debilitated after vaccination. An examination of her microbiome revealed zero bifidobacteria and actinobacteria. This raised questions about whether the vaccine or spike protein affected her gut microbiome. Similar findings were observed in other vaccine-injured patients, all showing zero bifidobacteria. One patient’s count dropped from one million to zero. This suggests the spike protein, possibly combined with nanoparticles and other contaminants, may enter the bloodstream and affect the gut microbiome, leading to conditions like leaky gut. The implications of these findings remain unpublishable and largely ignored by the medical community.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe, decreased in patients before and after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker emphasized the importance of research in understanding and addressing these issues.

Bifidobacteria are important for immunity, but they are not the only important microbe. The speaker notes that bifidobacteria are the microbe that is disappearing. Analyzing thousands of stool samples, out of 4,000 stool samples, there are only four that can be said with certainty “these are both microbiomes.” Out of the thousand samples analyzed, less than five percent have bifidobacteria. The speaker highlights that loss of bifidobacteria is not universally linked to all conditions. It is present in Alzheimer's disease, with Alzheimer's patients having lots of bifidobacteria; Lyme disease patients also have lots of bifidobacteria. Crohn’s patients that have never been treated have lots of bifidobacteria. In autistic kids, there is enough data now; they showed data initially, and now more data and more labs reproducing that data show that there are lots of bifidobacteria in autism. The speaker mentions that “Loss of bifidobacteria in autism” can be addressed by replenishing bifidobacteria, and refers to this as proof of concept that the judge at the American College of Gastroenterology acknowledged, noting that this is what is needed to advance science to understand. Loss of bifidobacteria was also noticed in patients with invasive cancer. The speaker says they published that data at the American College of Gastroenterology and presented at Digestive Disease Week, showing that if a patient had a non-aggressive cancer, they had a better level of bifidobacteria than a patient with invasive cancer who has zero. Regarding therapeutic implications, the speaker asks whether modulating the gut to improve bifidobacteria is feasible and notes collaboration with multiple centers, including MD Anderson. The implication is to start modulating the gut and improving bifidobacteria in cancer patients rather than relying solely on chemotherapy and immunotherapy. In summary, the research conducted at Progena Biome—a research lab—focuses on bifidobacteria, its variable presence across diseases, its potential replenishment in autism, and its association with cancer progression, highlighting ongoing work to modulate the gut microbiome as a therapeutic strategy.

Speaker 0: Bifidobacteria was absent in kids with autism, that Bifidobacteria was absent in Alzheimer's. Bifidobacteria was absent in long haulers, vaccine injured, Lyme patients, Crohn's patients, invasive cancer. When you look at who has Bifidobacteria, the newborns have a lot of Bifidobacteria, old people have zero Bifidobacteria. Nursing home dying, zero Bifidobacteria. The process of aging is really this loss of Bifidobacteria. Expanded: if you look at and you believe the Bible, you know, people lived a lot longer. In biblical times than we are right now. We're barely making it to seventy, eighty and not really healthy seventy, eighty. You know, the mind starts going. So, is the mind starting to go because of the loss of Bifidobacteria? And, when you start looking at, well, what improves Bifidobacteria, right? So, our lab discovered vitamin C improves Bifidobacteria. Okay. Our lab discovered bovine immunoglobulins, the blood of the cow spun around that clear stuff, provided that the cow is not on a lot of antibiotics, is not given a lot of hormones, is not given like thousands of vaccines. So when you start looking at all that, you start seeing the importance of Bifidobacteria and you start seeing, like even me, you know, with Progena Biome, looking at the stool samples before the pandemic, during the pandemic and after the pandemic, there is a lot of disappearance of Bifidobacteria. Is that why we're having an increase in Alzheimer's, increase in cancer? Have we demolished this bifidobacteria? So, to me, that's a very important microbe that I believe is our longevity, if we can retain it. And it's not easy to retain in a world that's toxic in a way and in a world where we are, you know, put you know, given media full of stress, where we are divided, where we are, you know, constantly nervous of the next pandemic or the next virus, you know, it's it's almost like this bottle that you're shaking and it's full of gas and you just need to put it on the counter and let it just calm down, right? So, I think that's, it's a very important microbe.

The speaker, a gastroenterologist, discusses research on the microbiome's role in COVID-19 and challenges encountered publishing findings that contradicted the public health narrative. Early research identified the full viral sequence in stool samples, where it lingered for up to 45 days, and noted hydroxychloroquine and azithromycin killed the virus in stools but harmed the microbiome, leading to the addition of vitamins C, D, and zinc to treatment protocols. An initial FDA exemption for clinical trials using this combination was revoked, and media-fueled fear around hydroxychloroquine hindered recruitment. Research revealed that patients with severe COVID-19 lacked bifidobacteria, a key microbe for immunity, which is abundant in newborns but decreases with age. Vitamin C and ivermectin were found to increase bifidobacteria levels. A hypothesis that ivermectin increased bifidobacteria was retracted after being widely read. Research on mRNA vaccines showed they killed bifidobacteria, a finding presented at a gastroenterology conference and linked to conditions like Crohn's disease, Lyme disease, and invasive cancer. The speaker concludes that interference with research during the pandemic hindered scientific progress and that established clinical trial guidelines were not followed.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed a lack of bifidobacteria in newborns born to vaccinated mothers, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.